4
Changes in Ownership
PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001493152-22-022233
Options or other derivatives
- Director acquired 0 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Pershing Edward Director | 2022-07-15 | Grant or award · 8% Unsecured Convertible Promissory Note due 2023 | +0 | $150,000.00 | $0 | D | |
| Pershing Edward Director | 2022-07-27 | Grant or award · 8% Unsecured Convertible Promissory Note due 2023 | +0 | $75,000.00 | $0 | D | |
Loading xslF345X03/ownership.xml…